These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1348506)

  • 21. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y. Differential binding to rat intestinal laterobasal membranes.
    Nguyen TD; Heintz GG; Kaiser LM; Staley CA; Taylor IL
    J Biol Chem; 1990 Apr; 265(11):6416-22. PubMed ID: 2156850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.
    Jørgensen JC; Fuhlendorff J; Schwartz TW
    Eur J Pharmacol; 1990 Sep; 186(1):105-14. PubMed ID: 2178092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The irreversible alpha-blocker benextramine interacts with two different thiol groups.
    Melchiorre C; Gallucci P
    Farmaco Sci; 1983 Dec; 38(12):950-6. PubMed ID: 6141952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiparallel pancreatic polypeptide fold in the binding of neuropeptide Y to Y1 and Y2 receptors.
    Fuhlendorff J; Johansen NL; Melberg SG; Thøgersen H; Schwartz TW
    J Biol Chem; 1990 Jul; 265(20):11706-12. PubMed ID: 2164012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the neuropeptide Y receptor in the rat brain and intestine.
    Taylor IL; Mannon PJ; Heintz GG; Kaiser LM; Nguyen TD
    Ann N Y Acad Sci; 1990; 611():48-57. PubMed ID: 2174223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel cyclic analog of neuropeptide Y specific for the Y2 receptor.
    Beck-Sickinger AG; Grouzmann E; Hoffmann E; Gaida W; van Meir EG; Waeber B; Jung G
    Eur J Biochem; 1992 Jun; 206(3):957-64. PubMed ID: 1318842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Y1 and Y2 receptors for neuropeptide Y.
    Sheikh SP; Håkanson R; Schwartz TW
    FEBS Lett; 1989 Mar; 245(1-2):209-14. PubMed ID: 2538360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
    Wahlestedt C; Regunathan S; Reis DJ
    Life Sci; 1992; 50(4):PL7-12. PubMed ID: 1310131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a receptor protein for neuropeptide Y in rabbit kidney. G-protein association and inhibition of adenylate cyclase.
    Gimpl G; Wahl J; Lang RE
    FEBS Lett; 1991 Feb; 279(2):219-22. PubMed ID: 1848189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-terminal modifications of neuropeptide Y and its analogs leading to selectivity for the mouse brain receptor over the porcine spleen receptor.
    Krstenansky JL; Owen TJ; Payne MH; Shatzer SA; Buck SH
    Neuropeptides; 1990 Nov; 17(3):117-20. PubMed ID: 1964720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents.
    Parker SL; Parker MS
    Regul Pept; 2000 Feb; 87(1-3):59-72. PubMed ID: 10710289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y (18-36) is a competitive antagonist of neuropeptide Y in rat cardiac ventricular membranes.
    Balasubramaniam A; Sheriff S
    J Biol Chem; 1990 Sep; 265(25):14724-7. PubMed ID: 2168390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis.
    Härfstrand A; Fuxe K; Agnati L; Fredholm B
    J Neural Transm; 1989; 75(2):83-99. PubMed ID: 2537374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of alpha-1 adrenergic receptors in the stimulating effect of neuropeptide Y (NPY) on rat behavioural activity.
    Smiałowska M; Gastoł-Lewińska L; Tokarski K
    Neuropeptides; 1994 Apr; 26(4):225-32. PubMed ID: 7913209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solubilization of the neuropeptide Y receptor from rat brain membranes.
    Mannon PJ; Mervin SJ; Taylor IL
    J Neurochem; 1991 May; 56(5):1804-9. PubMed ID: 1849554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha 2-adrenergic receptor turnover in adipose tissue and kidney: irreversible blockade of alpha 2-adrenergic receptors by benextramine.
    Taouis M; Berlan M; Lafontan M
    Mol Pharmacol; 1987 Jan; 31(1):89-96. PubMed ID: 2880286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.